Daniel Saez is an experienced professional specializing in biomarker strategy and operations within clinical trials. Currently serving as a Biomarker Operations Specialist at BioNTech SE since May 2024, Daniel executes biomarker strategy throughout the sample lifecycle in global oncology clinical trials. Prior to this role, Daniel was a Scientific Project Manager in the Vaccine Immunology Program at the National Institute of Allergy and Infectious Diseases from February 2023 to May 2024, managing clinical testing for HIV trials. Additionally, Daniel held positions at the GO2 Foundation for Lung Cancer, focusing on precision medicine and biomarker testing, and served as the General and Financial Manager at America's Ballet School from 2011 to 2017. Daniel holds a Master of Science in Physiology and Pharmacology from Wake Forest University Graduate School and a Bachelor of Science in Biomedical Sciences from the University of South Florida.
This person is not in the org chart
This person is not in any teams
This person is not in any offices